Advertisement

Meyka AI - Contribute to AI-powered stock and crypto research platform
Meyka Stock Market API - Real-time financial data and AI insights for developers
Advertise on Meyka - Reach investors and traders across 10 global markets
Loading...

AlerisLife Inc.

ALRNASDAQ
Healthcare
Medical - Care Facilities
$1.32
$0.00(0.00%)
U.S. Market opens in 3h 24m

AlerisLife Inc. Fundamental Analysis

AlerisLife Inc. (ALR) shows weak financial fundamentals with a PE ratio of -1.40, profit margin of -3.18%, and ROE of -15.17%. The company generates $1.0B in annual revenue with N/A year-over-year growth of N/A.

Key Strengths

Cash Position189.24%
PEG Ratio-0.01

Areas of Concern

ROE-15.17%
Operating Margin-0.67%
We analyze ALR's fundamental strength across five key dimensions.

The stock receives a Fundamental Health Score of 8.9/100 based on profitability, valuation, growth, and balance sheet metrics. The F grade reflects weak fundamentals and significant financial concerns.

Fundamental Health Score

F
8.9/100

We analyze ALR's fundamental strength across five key dimensions:

Efficiency Score

Weak

ALR struggles to generate sufficient returns from assets.

ROA > 10%
-7.91%

Valuation Score

Excellent

ALR trades at attractive valuation levels.

PE < 25
-1.40
PEG Ratio < 2
-0.01

Growth Score

Weak

ALR faces weak or negative growth trends.

Revenue Growth > 5%
N/A
EPS Growth > 10%
N/A

Financial Health Score

Excellent

ALR maintains a strong and stable balance sheet.

Debt/Equity < 1
0.11
Current Ratio > 1
1.33

Profitability Score

Weak

ALR struggles to sustain strong margins.

ROE > 15%
-1517.28%
Net Margin ≥ 15%
-3.18%
Positive Free Cash Flow
No

Key Financial Metrics

Is ALR Expensive or Cheap?

P/E Ratio

ALR trades at -1.40 times earnings. This suggests potential undervaluation.

-1.40

PEG Ratio

When adjusting for growth, ALR's PEG of -0.01 indicates potential undervaluation.

-0.01

Price to Book

The market values AlerisLife Inc. at 0.23 times its book value. This may indicate undervaluation.

0.23

EV/EBITDA

Enterprise value stands at -6.33 times EBITDA. This is generally considered low.

-6.33

How Well Does ALR Make Money?

Net Profit Margin

For every $100 in sales, AlerisLife Inc. keeps $-3.18 as profit after all expenses.

-3.18%

Operating Margin

Core operations generate -0.67 in profit for every $100 in revenue, before interest and taxes.

-0.67%

ROE

Management delivers $-15.17 in profit for every $100 of shareholder equity.

-15.17%

ROA

AlerisLife Inc. generates $-7.91 in profit for every $100 in assets, demonstrating efficient asset deployment.

-7.91%

Following the Money - Real Cash Generation

Operating Cash Flow

AlerisLife Inc. generates limited operating cash flow of $-8.02M, signaling weaker underlying cash strength.

$-8.02M

Free Cash Flow

AlerisLife Inc. generates weak or negative free cash flow of $-18.02M, restricting financial flexibility.

$-18.02M

FCF Per Share

Each share generates $-0.54 in free cash annually.

$-0.54

FCF Yield

ALR converts -38.51% of its market value into free cash.

-38.51%

Financial Ratios Analysis

Valuation Ratios

P/E Ratio

Price to earnings ratio

-1.40

vs 25 benchmark

PEG Ratio

Price/earnings to growth ratio

-0.01

vs 25 benchmark

P/B Ratio

Price to book value ratio

0.23

vs 25 benchmark

P/S Ratio

Price to sales ratio

0.05

vs 25 benchmark

Financial Health

Debt/Equity

Total debt to shareholders' equity

0.11

vs 25 benchmark

Current Ratio

Current assets to current liabilities

1.33

vs 25 benchmark

Efficiency Ratios

ROE

Return on equity percentage

-0.15

vs 25 benchmark

ROA

Return on assets percentage

-0.08

vs 25 benchmark

ROCE

Return on capital employed

-0.03

vs 25 benchmark

How ALR Stacks Against Its Sector Peers

MetricALR ValueSector AveragePerformance
P/E Ratio-1.4029.45 Better (Cheaper)
ROE-15.17%779.00% Weak
Net Margin-3.18%-24936.00% (disorted) Weak
Debt/Equity0.110.26 Strong (Low Leverage)
Current Ratio1.334.65 Neutral
ROA-7.91%-19344.00% (disorted) Weak

ALR outperforms its industry in 2 out of 6 key metrics, but lagging in ROE.

Historical Growth Performance

5-Year Growth Trajectory

This section reviews AlerisLife Inc.'s 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.

Revenue CAGR

N/A

Industry Style: Defensive, Growth, Innovation

EPS CAGR

N/A

Industry Style: Defensive, Growth, Innovation

FCF CAGR

N/A

Industry Style: Defensive, Growth, Innovation

Fundamental Analysis FAQ